XAIR
Beyond Air (XAIR)
$
27About Beyond Air (XAIR)
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Details
Daily high
$0.27
Daily low
$0.26
Price at open
$0.27
52 Week High
$1.78
52 Week Low
$0.24
Market cap
23.7M
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.4M
P/E ratio
-.25
Beyond Air News
Details
Daily high
$0.27
Daily low
$0.26
Price at open
$0.27
52 Week High
$1.78
52 Week Low
$0.24
Market cap
23.7M
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.4M
P/E ratio
-.25